Share Price:

APNASPENAspen Pharmacare Hldgs12099-359 (-2.88%)

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

Appointment of Alternate Director

Aspen has appointed Derek Thomas, BCom (Finance and Economics); BCom (Hons) (Economics); MCOM (Economics); MSc (Economics), as an alternate director to Pasco Dyani with effect from 6 February 2007. Since 2000, Derek has served as CEO of CEPPWAWU Investments (Pty) Ltd, a broad based black economic empowerment investment company (wholly owned by a Trust formed… Continue reading Appointment of Alternate Director

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: